C71.7 Malignant neoplasm: brain stem.
Midline glioma, WHO grade 4, likely H3K27M mutation, IDH1/2 mutations not detected. The tumor spreads to the right superior peduncle of the cerebellum.
Radiation therapy, chemotherapy (Temozolomide).
The prognosis remains poor, with a median survival of ~1 year from diagnosis.
Autologous DCV and CIK (16 doses) over a period of 13 months.
Patient is alive, stable disease, finished radiation therapy, chemotherapy and immunotherapy.